Drug Use Investigation for ALLERMIST

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01376206

Enrollment

2000

Registered

2011-06-20

Start date

2009-12-31

Completion date

2011-05-31

Last updated

2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinitis

Brief summary

To investigate possible problems or questions in safety and efficacy of ALLERMIST Nasal Spray in Japanese subjects with allergic rhinitis under the practical use conditions

Interventions

DRUGFluticasone

Collection of safety data

Study design

Observational model

OTHER

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Diagnosis of allergic rhinitis * Use ALLERMIST for the first time * Expected to use ALLERMIST for long-term (1 year)

Exclusion criteria

* Subjects with infection which fluticasone is not effective * Subjects with deep mycosis * Subjects with hypersensitivity to fluticason

Design outcomes

Primary

Measure	Time frame
The number of adverse events in Japanese subjects with allergic rhinitis treated with fluticasone nasal spray	Four weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026